主管:国家卫生健康委员会
主办:国家卫生计生委医院管理研究所
中国科学引文数据库(CSCD)来源期刊
中国科技论文统计源期刊 中国科技核心期刊
《中文核心期刊要目总览》入选期刊

Chinese Nursing Management ›› 2022, Vol. 22 ›› Issue (4): 609-613.doi: 10.3969/j.issn.1672-1756.2022.04.025

• Nursing Safety • Previous Articles     Next Articles

Clinical practice of standardization of tirofiban medication process in patients with progressive ischemic stroke

GUO Guili, CHANG Hong, GAO Lan, ZHAO Wenbo, MA Qingfeng   

  1. Stroke Acute Care Center of Neurology Department, Xuanwu Hospital Capital Medical University, Beijing, 100053, China
  • Online:2022-04-15 Published:2022-04-15
  • Contact: E-mail:changhong19791111@126.com

Abstract: Objective: To evaluate the clinical efficacy of standardized process of the medication administration of tirofiban in patients with progressive ischemic stroke. Methods: The problems linked in the usage of tirofiban was analyzed and a standardized process of medication administration after admission was formulated, including drug administration specifications, dedicated group prescription, a fast track for nuclear magnetic examination under multi-department cooperation, special frame of drug usage, and drug substances information column. Results: Compared with the non-standardized process of medication administration, the standardized process significantly reduced the waiting time of medication administration, drug interruption time, and accurate drug bridging time, respectively. Conclusion: The standardized process of the medication administration of tirofiban in patients with progressive ischemic stroke can effectively shorten the waiting time of medication administration, drug interruption time, and accurate the drug bridging time, which is beneficial for the safety of patient’s medication administration.

Key words: progressive ischemic stroke; tirofiban; medication administration; standardized process

CLC Number: R47